BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3191208)

  • 1. Hodgkin's disease in HIV-infected patients.
    Alfonso PG; Sañudo EF; Carretero JM; Galindo RC; Altozano JG; Gomez LP; Manga GP
    Biomed Pharmacother; 1988; 42(5):321-5. PubMed ID: 3191208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hodgkin's disease and infection with human immunodeficiency virus].
    Auguet Quintillá T; Pedro-Botet Montoya J; Planas Domingo J; Gallén Castillo M
    Sangre (Barc); 1992 Feb; 37(1):39-41. PubMed ID: 1374934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin's disease and AIDS. Presentation of 5 cases].
    García Alfonso P; Flores Sañudo E; Carrión Galindo R; Jara Sánchez C; Cosín Ochaita J
    Rev Clin Esp; 1988 Apr; 182(6):314-6. PubMed ID: 2457232
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical presentation of Hodgkin's disease in a patient at risk for the acquired immunodeficiency syndrome.
    Keyserlingk H; Ludwig WD; Seibt H; Rühl H; Höffken G
    Cancer Detect Prev; 1988; 12(1-6):243-8. PubMed ID: 3180129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
    Larraín C; Cuchacovich M; Conte G
    Rev Med Chil; 1987 Sep; 115(9):842-6. PubMed ID: 3506277
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
    Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
    J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease presenting as nephrotic syndrome.
    Agarwal S; Avasthi R; Tyagi SC; Singh K; Ram BK
    J Assoc Physicians India; 1994 Nov; 42(11):907-8. PubMed ID: 7868497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Infection by the human immunodeficiency virus and Hodgkin's disease].
    Andreu J; Jiménez-Mejías ME; Chinchón I; Borderas F
    Rev Clin Esp; 1990 Jun; 187(1):42-3. PubMed ID: 2270333
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-associated lymphoma: report of three cases.
    Mwangi JW
    East Afr Med J; 1999 Mar; 76(3):176-7. PubMed ID: 10442121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous Hodgkin's disease and non-Hodgkin's lymphoma in an adult with acquired immunodeficiency syndrome (AIDS).
    Gallagher JG; Meschter SC
    Cancer Detect Prev; 1990; 14(3):395-401. PubMed ID: 2386977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.